Ben Marsh joined global law firm Goodwin’s Life Sciences and Technology practices as a partner in the New York office
Marsh advises U.S. and international issuers and underwriters on a broad range of transactions, including in the life sciences and technology industries. He complements his legal practice with extensive experience as an equity capital markets investment banker, focusing on initial public offerings and other public and private corporate finance transactions, including follow-on equity, equity-linked, debt, preferred and structured transactions.
Marsh also advises companies on a range of corporate governance, investor relations and other corporate matters._x000D_
“Ben’s investment banking background and experience advising underwriters add significant depth to our premier capital markets practice and complement our robust issuer-side team,” said Mitchell Bloom, chair of the Life Sciences practice. “We are thrilled to welcome him to the firm as we continue to focus on Goodwin’s unique positioning at the intersection of innovation and capital across the life sciences and technology industries.”
Prior to his legal career, he spent nearly a decade in senior capital markets investment banking roles.
